Dianthus Therapeutics Statistics
NASDAQ: DNTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
84.55-0.28 (-0.33%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Dianthus Therapeutics by the numbers
Dianthus Therapeutics has a market capitalization of $4.76 billion based on 56.31M shares outstanding. With trailing EPS of $-4.08, Dianthus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.1% below its 50-day average and 3.7% below its 200-day average.
Average daily trading volume is 848.96K shares, or about $71.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DNTH valuation vs. peer median
| Metric | DNTH | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.76B | $4.75B | +0% |
| Avg. volume | 848.96K | 1.94M | -56% |
Peer median across 8 companies: ERAS, PTCT, LQDA, COGT, TVTX, MANE, IONS, BLTE.
Valuation
- Market cap
- $4.76B
- Price / sales (latest FY)
- 2,338.53
- EPS (TTM)
- $-4.08
- Shares outstanding
- 56.31M
Price and trading
- Previous close
- 84.83
- Open
- 83.62
- Day range
- 82.58 – 85.67
- 52-week range
- 35.84 – 117.88
- 52-week change
- +103.98%
- Beta
- —
- Volume
- 784.84K
- Average volume
- 848.96K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 4.76B
- Forward Pe
- -19.83
- Eps
- -4.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 117.88
- Week52 Low
- 35.84
- Avg Volume
- 848.96K
- Shares Outstanding
- 56.31M
- Ma50
- 86.37
- Ma200
- 87.81
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -28.27%
- Pct From52w Low
- 135.91%